Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

PanGenetics Receives Approval For Clinical Evaluation Of Anti-NGF Antibody In Patients With Chronic Pain
PanGenetics B.V. announced that the Competent Authority of the Netherlands has approved the Clinical Trials Application for a first-in-man study with antibody PG110. This humanized antibody is a member of the class of Nerve Growth Factor (NGF) inhibitors which represent a promising novel approach in the treatment of chronic pain. PG110 will be evaluated in patients suffering from pain caused by osteoarthritis (OA). The clinical trial is designed as a double blind, placebo controlled study and will be conducted in a single site in Utrecht, the Netherlands, in collaboration with Kendle International.

Which? Warns Consumers Against Costly Genetic Tests
As the Lords Science Committee publishes its report on genomic medicine, Which? scientific policy adviser, Dr Rob Reid, says:
News of the day
Anthrax Attack Requires Early Detection & Quick Response
A large attack on a major metropolitan area with airborne anthrax could affect more than a million people, necessitating their treatment with powerful antibiotics. A new study finds that in order for a response to be effective, quick detection and treatment are essential, and any delay beyond three days would overwhelm hospitals with critically ill people.
Endocrinology

318 Articles On The H1N1 Swine Flu Virus Available Online Free Of Charge On SpringerLink

Springer Science+Business Media is offering all journal articles which deal with the H1N1 virus, or swine flu, free of charge on its online information platform http://www.springerlink.com. The articles can be found by using the search term "H1N1." A total of 318 scientific articles will be available to print out or download from now until 31 December 2009. In June 2009, the World Health Organization raised the worldwide pandemic alert level to Phase 6 in response to the ongoing global spread of the H1N1 virus. A Phase 6 designation indicates that a global pandemic is underway. More than 70 countries are now reporting cases of human infection with H1N1 flu. Eric Merkel-Sobotta, Executive Vice President Corporate Communications of Springer Science+Business Media, said, "As a global scientific, technical and medical publisher, Springer plays a major role in the distribution of scientific information and access to knowledge and research. Therefore we are making all studies, published up to now on the H1N1 virus, freely available online on SpringerLink. By doing this, we hope to push forward scientific research on the causes, cures and other facets of this virus." Renate Bayaz Springer


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009